Share on StockTwits

Research analysts at Sterne Agee assumed coverage on shares of Humana (NYSE:HUM) in a report released on Friday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $139.00 price target on the stock. Sterne Agee’s target price would indicate a potential upside of 8.76% from the stock’s previous close.

A number of other analysts have also recently weighed in on HUM. Analysts at Zacks reiterated a “neutral” rating on shares of Humana in a research note on Thursday, June 19th. They now have a $131.00 price target on the stock. Separately, analysts at Stifel Nicolaus upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. They now have a $155.00 price target on the stock. Finally, analysts at Stifel upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. They now have a $155.00 price target on the stock. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the company. Humana currently has an average rating of “Hold” and a consensus target price of $126.43.

Humana (NYSE:HUM) traded down 0.70% during mid-day trading on Friday, hitting $126.90. 275,301 shares of the company’s stock traded hands. Humana has a 1-year low of $82.14 and a 1-year high of $129.14. The stock has a 50-day moving average of $124.0 and a 200-day moving average of $110.0. The company has a market cap of $19.642 billion and a price-to-earnings ratio of 17.97.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $2.35 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.94 by $0.41. During the same quarter last year, the company posted $2.69 earnings per share. Analysts expect that Humana will post $7.81 EPS for the current fiscal year.

Humana Inc (NYSE:HUM) is a health care company.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.